Half-year report · HY
2533.TEDINET S100YTO3
Period2026-01-01 → 2026-06-30
Filed2026-08-06
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥43.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥87.6bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥42.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥2.6bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.6bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.3bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.7bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.5bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥55.8bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥59.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥53.9bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥27.6bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥32.3bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥28.2bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥25.5bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥831m | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥884m | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥826m | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥879m | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥797m | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥882m | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥35m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.6bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥377m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.6bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.06 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.72 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.57 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.2% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥43m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥43m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥5m |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥6m |
| Enzymatic Medicinereportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.0bn |
| Enzymatic Medicinereportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.0bn |
| Enzymatic Medicinereportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥936m |
| Liquorreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥40.0bn |
| Liquorreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥40.0bn |
| Liquorreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥6m |
| Liquorreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.2bn |
| Real Estatereportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥665m |
| Real Estatereportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥665m |
| Real Estatereportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥396m |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥43.6bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥43.6bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥6m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥49m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥44m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥17m |
| Enzymatic Medicinereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Enzymatic Medicinereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Enzymatic Medicinereportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥568m |
| Liquorreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥39.1bn |
| Liquorreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥39.0bn |
| Liquorreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥12m |
| Liquorreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Real Estatereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥660m |
| Real Estatereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥660m |
| Real Estatereportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥389m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥42.2bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥42.2bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥12m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥2.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 577
| Item | Context | Value | Unit |
|---|---|---|---|
| Taxes and dues sga | Prior1InterimDuration | 192000000 | JPY |
| Taxes and dues sga | InterimDuration | 194000000 | JPY |
| Depreciation sga | Prior1InterimDuration | 131000000 | JPY |
| Depreciation sga | InterimDuration | 159000000 | JPY |
| Rent expenses sga | Prior1InterimDuration | 161000000 | JPY |
| Rent expenses sga | InterimDuration | 161000000 | JPY |
| Amortization of goodwill sga | Prior1InterimDuration | 1000000 | JPY |
| Amortization of goodwill sga | InterimDuration | － | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00397-000LiquorReportableSegmentsMember | 39044000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00397-000EnzymaticMedicineReportableSegmentsMember | 2517000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00397-000RealEstateReportableSegmentsMember | 660000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 42223000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 44000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 42268000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00397-000LiquorReportableSegmentsMember | 12000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00397-000EnzymaticMedicineReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00397-000RealEstateReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | 12000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 5000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -17000000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E00397-000LiquorReportableSegmentsMember | 39057000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E00397-000EnzymaticMedicineReportableSegmentsMember | 2517000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E00397-000RealEstateReportableSegmentsMember | 660000000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 42236000000 | JPY |
| Net sales | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 49000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -17000000 | JPY |
| Net sales | Prior1InterimDuration | 42268000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00397-000LiquorReportableSegmentsMember | 1352000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00397-000EnzymaticMedicineReportableSegmentsMember | 568000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00397-000RealEstateReportableSegmentsMember | 389000000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 2310000000 | JPY |
| Operating income | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1InterimDuration | 2316000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E00397-000LiquorReportableSegmentsMember | 39997000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E00397-000EnzymaticMedicineReportableSegmentsMember | 2966000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E00397-000RealEstateReportableSegmentsMember | 665000000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 43629000000 | JPY |
| Revenues from external customers | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 43000000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 43673000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E00397-000LiquorReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E00397-000EnzymaticMedicineReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E00397-000RealEstateReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -6000000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |